
ResMed RMD
$ 192.74
-1.05%
Annual report 2022
added 08-12-2022
ResMed DPO Ratio 2011-2026 | RMD
Annual DPO Ratio ResMed
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 34.9 | 36.8 | 37 | 39.5 | 34.6 | 39.1 | 43.8 | 44.4 | 55.2 | 38.6 | 36.7 | 40.1 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 55.2 | 34.6 | 40.1 |
Quarterly DPO Ratio ResMed
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 38.3 | 39.4 | 35.8 | 16 | 36.9 | 32.4 | 36.9 | 36.7 | 36.4 | 33.1 | 35.5 | 34.2 | 37.4 | 34.5 | 35.6 | 31.6 | 31.8 | 29.6 | 37.2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 39.4 | 16 | 34.2 |
DPO Ratio of other stocks in the Medical instruments industry
| Issuer | DPO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Atrion Corporation
ATRI
|
31.9 | - | - | $ 810 M | ||
|
The Cooper Companies
COO
|
72.6 | $ 67.76 | -0.18 % | $ 13.5 B | ||
|
Luminex Corporation
LMNX
|
45.3 | - | - | $ 1.75 B | ||
|
Glaukos Corporation
GKOS
|
61.5 | $ 130.14 | 2.63 % | $ 7.44 B | ||
|
Akers Biosciences, Inc.
AKER
|
218 | - | -9.52 % | $ 20.6 M | ||
|
Alcon
ALC
|
63.6 | $ 66.29 | -0.84 % | $ 40.4 B | ||
|
Intuitive Surgical
ISRG
|
23.9 | $ 416.55 | 1.34 % | $ 149 B | ||
|
ICU Medical
ICUI
|
39.2 | $ 143.72 | 1.07 % | $ 3.54 B | ||
|
iRhythm Technologies
IRTC
|
7.87 | $ 113.76 | 0.1 % | $ 3.64 B | ||
|
Repro Med Systems
KRMD
|
46.1 | $ 3.87 | -3.25 % | $ 179 M | ||
|
LeMaitre Vascular
LMAT
|
13.9 | $ 91.92 | -0.04 % | $ 2.08 B | ||
|
Antares Pharma, Inc.
ATRS
|
93.7 | - | - | $ 955 M | ||
|
Masimo Corporation
MASI
|
84.4 | $ 179.95 | - | $ 9.59 B | ||
|
Cantel Medical Corp.
CMD
|
26.4 | - | -1.18 % | $ 3.4 B | ||
|
Merit Medical Systems
MMSI
|
30.3 | $ 66.94 | 0.62 % | $ 3.96 B | ||
|
CRH Medical Corporation
CRHM
|
3.31 | - | - | $ 282 M | ||
|
Hill-Rom Holdings, Inc.
HRC
|
61.4 | - | -0.05 % | $ 10.3 B | ||
|
Ekso Bionics Holdings
EKSO
|
91.4 | - | - | $ 28.6 M | ||
|
Microbot Medical
MBOT
|
34.9 | $ 1.82 | 2.25 % | $ 83.3 M | ||
|
Varian Medical Systems, Inc.
VAR
|
39.5 | - | -0.02 % | $ 16.3 B | ||
|
Milestone Scientific
MLSS
|
66.3 | $ 0.34 | -3.59 % | $ 27.9 M | ||
|
electroCore
ECOR
|
195 | $ 9.11 | -11.12 % | $ 77.3 K | ||
|
Envista Holdings Corporation
NVST
|
54.2 | $ 24.68 | 0.33 % | $ 4.15 B | ||
|
Haemonetics Corporation
HAE
|
39.4 | $ 76.91 | -1.65 % | $ 3.63 B | ||
|
Isoray
ISR
|
58.4 | - | 0.03 % | $ 108 M | ||
|
STERIS plc
STE
|
34.2 | $ 205.93 | -0.79 % | $ 20.2 B | ||
|
STAAR Surgical Company
STAA
|
37 | $ 28.37 | - | $ 1.41 B | ||
|
InfuSystem Holdings
INFU
|
59.7 | $ 8.8 | -3.93 % | $ 182 M | ||
|
Teleflex Incorporated
TFX
|
47.7 | $ 130.09 | -0.3 % | $ 5.8 B | ||
|
Utah Medical Products
UTMD
|
17.8 | $ 69.87 | 2.99 % | $ 226 M | ||
|
West Pharmaceutical Services
WST
|
45.7 | $ 331.43 | 0.79 % | $ 24 B | ||
|
Pulse Biosciences
PLSE
|
1.51 K | $ 25.93 | 6.38 % | $ 1.75 B | ||
|
DENTSPLY SIRONA
XRAY
|
53.7 | $ 10.14 | 0.5 % | $ 2.02 B | ||
|
Retractable Technologies
RVP
|
46 | $ 0.67 | -5.2 % | $ 20.1 M | ||
|
Pro-Dex
PDEX
|
35.4 | $ 63.72 | 2.44 % | $ 210 M | ||
|
Predictive Oncology
POAI
|
7.25 K | - | - | $ 31.1 M | ||
|
BioLife Solutions
BLFS
|
25.9 | $ 26.69 | 2.26 % | $ 1.27 B | ||
|
Stereotaxis
STXS
|
124 | $ 1.84 | 0.55 % | $ 167 M | ||
|
Baxter International
BAX
|
45.6 | $ 20.81 | -0.24 % | $ 10.7 B | ||
|
AtriCure
ATRC
|
68.7 | $ 27.98 | -2.81 % | $ 1.34 B | ||
|
Harvard Bioscience
HBIO
|
42 | $ 5.99 | -1.48 % | $ 266 M | ||
|
NeuroMetrix
NURO
|
78.1 | - | 5.05 % | $ 9.02 M | ||
|
AngioDynamics
ANGO
|
96.2 | $ 11.98 | -0.99 % | $ 489 M | ||
|
Becton, Dickinson and Company
BDX
|
59.3 | $ 145.52 | -0.49 % | $ 41.9 B | ||
|
Nephros
NEPH
|
39.8 | $ 3.13 | -6.29 % | $ 33.2 M | ||
|
OraSure Technologies
OSUR
|
40.1 | $ 4.17 | -0.24 % | $ 306 M | ||
|
Repligen Corporation
RGEN
|
32.2 | $ 130.87 | 0.21 % | $ 7.36 M |